The research strategy presented here involves four assumptions: (1) Rett syndrome exists; (2) a single cause will eventually be found to account for the majority of cases presently assigned to this disease category; (3) it is genetically determined; and (4) it represents a neurodegenerative disorder that can be defined by quantitative studies of nervous system structure and function. The strategy proposed here involves the comprehensive study of 100 patients with the classic Rett syndrome phenotype. Studies include the (1) search for a diagnostic marker; (2) high-resolution cytogenetic banding techniques, (3) quantitative morphologic studies of postmortem brain tissue as well as neurochemical analyses including autoradiographic techniques, radioimmunoassays, and in situ hybridization; and (4) positron emission tomography studies of cerebral glucose metabolism and neurotransmitters. (J Child Neurol 1988;3(Suppl):S78-S86).
Get full access to this article
View all access options for this article.
References
1.
Hagberg B., Aicardi J., Dias K., et al: A progressive syndrome of autism, dementia, ataxia and loss of purposeful hand use in girls: Rett syndrome: Report of 35 cases. Ann Neurol1983;14: 471-479.
2.
The Rett Syndrome Diagnostic Criteria Work Group: Diagnostic criteria for Rett syndrome. Ann Neurol1988;23:425-428.
3.
Hyman SL, Batshaw ML: A case of ornithine transcarbamylase deficiency with Rett syndrome manifestations . Am J Med Genet1986;24(suppl 1):339-343.
4.
Opitz JM, Lewin SO: Rett syndrome-a review and discussion of syndrome delineation and syndrome definition. Brain Dev1987;9:445-450.
5.
Hagberg B., Witt-Engerström I.: Rett syndrome: Epidemiology and nosology-Progress in knowledge 1986-a conference communication. Brain Dev1987;9:451-457.
6.
McKusick VA: On lumpers and splitters, or the nosology of genetic disease. Perspect Biol Med1969;12:298-318.
7.
Opitz JM: Rett syndrome: Some comments on terminology and diagnosis. Am J Med Genet1986;24(Suppl 1):27-37.
8.
Tariverdian G., Kantner G., Vogel F.: A monozygotic twin pair with Rett syndrome . Hum Genet1987;75:88-90.
9.
Wahlstrom J. : Practical and theoretical considerations concerning the genetics of the Rett syndrome. Brain Dev1987;9:466-468.
10.
Coleman M., Naidu S., Murphy M., et al: A set of monozygotic twins with Rett syndrome. Brain Dev1987;9:475-478.
11.
Partington MW: Rett syndrome in monozygotic twins. Am J Med Genet1988;29:633-637.
12.
Hanefeld F. : The clinical pattern of Rett syndrome. Brain Dev1985;7:320-325.
13.
Richardson EP: Parkinson's disease, editorial. Ann Neurol1986; 20:447-448.
14.
Uhl GR, Hackney GO, Torchia M., et al: Parkinson's disease: Nigral receptor changes support peptidergic role in nigrostriatal modulation. Ann Neurol1986;20:194-203.
15.
Price DL, Koo EH, Warren AC, et al: Molecular and Cellular Biology of Alzheimer's disease, in Jones EG (ed): Molecular Biology of the Human Brain. New York, Alan R Liss Inc, 1988; pp 133-139.
16.
Martin JB, Gusella JF: Huntington's disease. Pathogenesis and management. N Engl J Med1986;315:1257-1276.
17.
Opitz JM, Reynolds JF, Spano LVM, et al: The Rett syndrome. Am J Med Genet1986;24(Suppl 1):1-415.
18.
Haas RH, Rice MA, Trauner DA, et al: Therapeutic effects of a ketogenic diet in Rett syndrome. Am J Med Genet1986 ;24 :225-246.
19.
Philippart M., Brown WJ: Dystonia and lactic acidosis: New features of Rett's syndrome. Ann Neurol1984;16:387.
20.
Bachmann C. , Schaub J., Colombo JF, et al: Rett syndrome revisited : A patient with biotin dependency. Eur J Pediatr1986 ; 144:563-566.
21.
Naidu S., Chatterjee S., Murphy M., et al: Rett syndrome. Brain Dev1987 ;9:525-529.
22.
Jellum E., Thorsrud AK: High resolution two-dimensional protein electrophoresis in clinical chemistre . Scand J Clin Lab Invest1986;46(Suppl 184):71-76.
23.
Goodman SI, Markey SP: Diagnosis of organic acidemias by gas chromatography-mass spectrometry , Lab Res Methods Biol Med1981;6:1-158.
24.
Matalon R., Michals K., Sebesta D., et al: Aspartoacylase deficiency in patients with Canavan disease. Am J Med Genet1988;29:463-471.
25.
Comings DE: The genetics of Rett syndrome: The consequences of a disorder where every case is a new mutation. Am J Med Genet1986 ;24:383-388.
26.
Schmickel RD : Contiguous gene syndromes: a component of recognizable syndromes. J Pediatr1986;109:231-241.
27.
Lindenbaum RHG , Clarke C., Patel M., et al: Muscular dystrophy in an X:1 translocation female suggests that Duchenne is on X-chromosome short arm. J Med Genet1979;16:389-392.
28.
McKusick VA : The morbid anatomy of the human genome: a review of gene mapping in clinical medicine. Medicine1986;65: 1-32.
29.
Hodgson SV, Neville B., Jones RW, et al: Two cases of X/ autosome translocation in females with incontinentia pigmenti: Hum Genet1985;71:231-234.
30.
Hagberg B.: Rett's syndrome: Prevalence and impact on progressive severe mental retardation in girls. Acta Paediatr Scand1985;74:405-408.
31.
Kerr AM, Stephenson JBP: Rett's syndrome in the west of Scotland. Br Med J1985;291:579-582.
32.
Roncuzzi L. , Fadda S., Mochi M., et al: Mapping of X-linked Becker muscular dystrophy through crossovers identified by DNA polymorphisms and by haplotype characterization in somatic cell hybrids. Am J Hum Genet1985;37:407-417.
33.
Jellinger K. , Seitelberger F.: Neuropathology of Rett syndrome . Am J Med Genet1986;24:259-288.
34.
Masson P.: Carcinoids (argentaffin-cell tumors) and nerve hyperplasia of the appendicular mucosa. Am J Pathol1928;4: 181-211.
35.
Papadimitrion JM, Hockey A., Tan N., et al: Rett syndrome: Abnormal membrane-bound lamellated inclusions in neurons and oligodendroglia . Am J Med Genet1988;29:365-368.
36.
Ross MH, Galaburda AM, Kemper TL: Down's syndrome: Is there a decreased population of neurons? Neurology1984;34: 909-916.
37.
Becker LE, Armstrong DL, Chan F.: Dendritic atrophy in children with Down's syndrome. Ann Neurol1986;20:520-526.
38.
Wisniewski KE, Dalton AJ, Crapper McL , et al: Alzheimer's disease in Down's syndrome: Clinicopathological studies. Neterology1985 ;35:957-961.
39.
Hedreen JC, Struble RG, Whitehouse PJ, et al: Topography of the magno-cellular forebrain system in human brain . J Neuropathol Exp Neurol1984;43:1-21.
40.
Riederer P. , Brucke T., Sofic E., et al: Neurochemical aspects of the Rett syndrome. Brain Dev1985 ;7:351-360.
41.
Riederer P. , Weiser M., Wichart I., et al: Preliminary brain autopsy findings in progredient Rett syndrome. Am J Med Genet1986; 24:305-315.
42.
Whitehouse PJ, Lynch D., Kuhar MJ: Effects of postmortem delay and temperature on neurotransmitter receptor binding in a rat model of the human autopsy process . J Neurochem1984;43:553-559.
43.
Kitt CA, Cork LC, Eidelberg F., et al: Injury of nigral neurons exposed to 1-methyl-4-phenyl-1,2,3,6-tetrahydropyridine: A tyrosine hydroxylase immunocytochemical study in monkey. Neuroscience1986;17:1089-1103.
44.
Bissette G. , Richardson C., Kizer JS, et al: Ontogeny of brain neurotensin in the rat: A radioimmunoassay study. J Neurochem1984;43:553-559.
45.
Price DL, Hoffman PN, Altschuler RJ, et al: Molecular approaches to human neurological diseases and their animal models, in Uhl GH (ed): In Situ Hybridization in Brain. New York, Plenum Publishing Corp, 1986, pp 171-180.
46.
D'Amato RJ, Alexander GM, Schwartzman RJ, et al: Evidence for neuromelanin involvement in MPTP-induced neurotoxicity. Nature1987 ;327:324-326.
47.
Cork LC, Sternberger NH, Sternberger LA, et al: Phosphorylated neurofilament antigens in neurofibrillary tangles in Alzheimer's disease. J Neuropathol Exp Neurol1986;45:56-64.
48.
Troncoso JC , Sternberger NH, Sternberger LA, et al: Immunocytochemical studies of neurofilament antigens in the neurofibrillary pathology induced by aluminum. Brain Res1986;304: 295-300.
49.
Niedermeyer E., Rett A., Renner H., et al: Rett syndrome and the electroencephalogram . Am J Med Genet1986;24(Suppl 1) :195-199.
50.
Verma NP, Chheda RL, Nigro MA, et al: Electroencephalographic findings in Rett syndrome. Electroencephalogr Clin Neurophysiol1986;64:394-401.
Boltshauser E., Lange B., Dumermuth G.: Differential diagnosis of syndromes with abnormal respiration (tachypnea-apnea). Brain Dev1987;9:462-465.
53.
Cirignotta F., Lugaresi E., Montagna P.: Breathing impairment in Rett syndrome. Am J Med Genet1986;24(suppl 1):167-173.
54.
Glaze DG, Frost. JD, Zoghbi HY, et al: Rett's syndrome characterization of respiratory pattern and sleep. Ann Neurol1987; 21:377-382.
55.
Friedland RP , Budinger TF, Ganz E., et al: Regional cerebral metabolic alterations in dementia of the Alzheimer type: Positron emission tomography with (18F) fluorodeoxyglucose. J Comput Assist Tomogr1983;7:590-598.
56.
Hasby JV, Grady CL, Duara R., et al: Neocortical metabolic abnormalities precede nonmemory cognitive defects in early Alzheimer's-type dementia. Arch Neurol1986;43:882-885.
57.
Young AB, Penney JB, Starosta-Rubinstein S., et al: PET scan investigations of Huntington's disease: Cerebral metabolic correlates of neurological features and functional decline. Ann Neurol1986;20:296-303.
58.
Chugani HT, Phelps ME: Maturational changes in cerebral function in infants determined by 18FDC positron emission tomography. Science1986;231:840-843.
59.
Wagner HN Jr, Burns HD, Dannals RF, et al: Imaging dopamine receptors in the human brain by positron tomography. Science1983;221:1264-1266.
60.
Burns HD, Dannals RF, Langstrom B., et al: (3-N[11C]Methyl) spiperone, a ligand binding to dopamine receptors: Radiochemical synthesis and biodistribution studies in mice. J Nucl Med1984;25:1222-1227.
61.
Frost JJ, Wagner HN Jr, Dannals RF: Imaging opiate receptors in the human brain by positron tomography . J Comput Assist Tomogr1985;9:231-236.
62.
Halldin C., Stone-Elander S., Farde L. et al: Preparation of 11C-labelled SCH 23390 for the in vivo study of dopamine D-1 receptors during positron emission tomography, Int J Appl Radiat Isotopes1986;37:1039-1043.
63.
Wong DF, Wagner HN Jr, Dannals RF: Effects of age on dopamine and serotonin receptors measured by positron tomography in the living human brain. Science1984;226: 1393-1395.
64.
Wong DF, Broussolle EP, Wand G., et al: In vivo measurement of dopamine receptors in human brain by positron emission tomography, age and sex differences. Ann NY Acad Sci1988; 515;203-214.
65.
Zoghbi HY, Percy AK, Glaze DG, et al: Reduction of biogenic amine levels in the Rett syndrome. N Engl J Med1985;313: 921-924.
66.
Perry TL, Dunn HG, Ho HH, et al: Cerebrospinal fluid values for monoamine metabolites, gamma-aminobutyric acid, and other amino compounds in Rett syndrome. J Pediatr1988;112: 234-238.
67.
Myer EC, Morris D., Dewey WL: Elevated beta-endorphins in Rett's syndrome. Ann Neurol1987;22:439.
68.
Breese GR, Baumeister AA, McCown TJ, et al: Behavioral differences between neonatal and adult 6-hydroxydopamine-treated rats to dopamine agonists: Relevance to neurological symptoms in clinical syndromes with reduced dopamine. J Pharmacol Exp Ther1984;231:343-354.
69.
Breese BR, Baumeister AA, McCown TJ, et al: Neonatal 6-hydroxydopamine treatment: Model of susceptibility for self-mutilation in the Lesch-Nyhan syndrome. Pharmacol Biochem Behav1984 ;21 :459-461.
70.
Breese BR, Baumeister A., Napier TC, et al: Evidence that D1 dopamine receptors contribute to the supersensitive behavioral responses induced by L-dihydroxyphenylalanine in rats treated neonatally with 6-hydroxydopamine. J Pharmacol Exp Ther1985;235:287-295.
71.
Harris JC, Wong DF, Wagner HN, et al: Positron emission tomographic study of D2 dopamine receptor binding and CSF biogenic amine metabolism in Rett syndrome. Am Med Genet1986;24:201-210.
72.
Wong DF, Braestrup C., Harris J., et al: Assessment of D1 andD2 dopamine receptors in Lesch-Nyhan syndrome by positron emission tomography, abstract. J Nucl Med1986;27:1027.
73.
Ravert HT, Wilson AA, Dannals RF, et al: Radiosynthesis of a selective dopamine D1 receptor antagonist: R(+)-7-chloro-8-hydroxy-3-[11C] methyl-1-phenyl-2,3,4,5,-tetrahydro-1H-E-benzazepine ([11C] SCH 23390). Int J Appl Radiat Isotopes1987;38: 305-306.
74.
Sedvall G., Farde L., Stone Elander S., et al: Dopamine D1-receptor binding in the living human brain. Adv Exp Med Biol1986;204:119-124.
75.
Wong DF, Wagner HN Jr, Tune LE, et al: Positron emission tomography reveals elevated D2 dopamine receptors in drug-naive schizophrenics. Science1986 ;234:1558-1563.
76.
Wong DF, Pearlson G., Tune L., et al: In vivo measurement of D2 dopamine receptor abnormalities in drug naive and treated manic-depressive patients. J Nucl Med1987;28:611.
77.
Wong DF, Singer H., Pearlson G., et al: D2 dopamine receptors in Tourette's syndrome and manic depressive illness. J Nucl Med1988;29:820-821.
78.
Naidu S., Wong DF, Sanche Roa P., et al: Rett syndrome: PET metabolic-clinical correlates. Ann Neurol1988;24:305.
